Key facts
- It has raised $24.0M.
- Notable investors include Unpopular Ventures, Spacestation (UK), Unruly Capital, The Pay It Forward Company, Other People's Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for NEXT Life Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for NEXT Life Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NEXT Life Sciences
Developer of a reproductive health biotechnology platform designed to revolutionize contraception through safe and effective non-hormonal methods. The company offers Plan A, a long-lasting, reversible, and on-demand male contraceptive developed to provide reliable pregnancy prevention without hormones or invasive procedures. By prioritizing safety, reversibility, and ease of use, the company addresses the long-standing gap in male contraceptive options and promotes shared responsibility in family planning. Supported by an experienced leadership team with expertise in medical device innovation and global commercialization, the company is enabling men to actively participate in reproductive health decisions while fostering a more balanced and equitable approach to contraception worldwide.
- Sector
- Healthcare
- HQ
- San Luis Obispo, CA, United States
- Founded
- 2022
- Employees
- 15
- Website
- nextlifesciences.org/
- Ownership
- Privately Held (backing)
NEXT Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NEXT Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NEXT Life Sciences in its N-PORT filings yet. We sweep new filings monthly.